Bona L, Pollavini S, Monza G
Clin Ther. 1985;7(4):474-9.
A double-blind, parallel-group trial was performed comparing efficacy and tolerability of two nonsteroidal anti-inflammatory drugs (NSAIDs)--pirprofen and noramidopyrine--in patients with postoperative pain. Thirty-four patients who had undergone orthopedic surgery were treated: 17 were given pirprofen (400 mg/4 ml) and 17 noramidopyrine (1 gm/2 ml). The first dose of medication was administered intramuscularly 30 minutes after the close of anesthesia, and a second administration was allowed six hours later if pain intensity did not decrease by 50% of initial visual analogue scale (VAS) values. Efficacy was tested both by the physician, using a rating scale, and by the patients, using a standard 100-mm VAS just before the administration of trial treatment and 2, 4, 6, and 12 hours later. The number of administrations of trial medication was also used as a criterion of efficacy. Both compounds significantly decreased (P less than 0.001) pain intensity (VAS assessment) over the trial period, but the effect of pirprofen lasted longer than that of noramidopyrine: only one of 17 patients who received pirprofen requested the second administration compared with ten of 17 patients who received noramidopyrine (P = 0.0019). The physician's evaluation performed after six hours evidenced the superiority of pirprofen (P less than 0.02) in comparison with noramidopyrine. No differences were recorded in heart rate, blood pressure, respiratory rate, or body temperature, and no unwanted effect was reported. These data provide evidence that treatment with NSAIDs can result in a well tolerated suppression of postoperative pain.
进行了一项双盲平行组试验,比较两种非甾体抗炎药(NSAIDs)——吡洛芬和安乃近——对术后疼痛患者的疗效和耐受性。34例接受骨科手术的患者接受了治疗:17例给予吡洛芬(400mg/4ml),17例给予安乃近(1g/2ml)。麻醉结束后30分钟肌肉注射首剂药物,如果疼痛强度未降低至初始视觉模拟量表(VAS)值的50%,6小时后可再次给药。疗效由医生使用评分量表进行测试,患者则在试验治疗给药前及给药后2、4、6和12小时使用标准的100mm VAS进行测试。试验药物的给药次数也用作疗效标准。在试验期间,两种药物均显著降低了疼痛强度(VAS评估)(P<0.001),但吡洛芬的效果持续时间比安乃近长:接受吡洛芬的17例患者中只有1例需要第二次给药,而接受安乃近的17例患者中有10例需要第二次给药(P=0.0019)。6小时后医生的评估证明吡洛芬比安乃近更具优势(P<0.02)。心率、血压、呼吸频率或体温均无差异,也未报告不良反应。这些数据表明,NSAIDs治疗可有效且耐受性良好地抑制术后疼痛。